一种依赖IRF-1的DNA损伤诱导的Apoptosis途径在mitogen激活的T淋巴细胞中
T Tamura1, M Ishihara, M S Lamphier
1Department of Immunology, Faculty of Medicine, University of Tokyo, Japan.
Nature
|August 17, 1995
概括
通过涉及干扰素调节因子 (IRF) -1 的途径,DNA损伤会触发T淋巴细胞的亡. 这种依赖IRF-1的途径与胸细胞中发现的p53途径不同,突出显示了独特的细胞防御机制.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 淋巴细胞容易发生DNA损伤诱导的亡,这种过程可能会阻止突变.
- 瘤抑制剂p53调节胸细胞的亡,但成熟的T淋巴细胞利用一个独立于p53的途径.
- 了解这些独特的亡途径对于癌症研究和免疫学至关重要.
研究的目的:
- 识别成熟T淋巴细胞中DNA损伤诱导的亡背后的分子机制.
- 调查干扰素调节因子 (IRF) -1 在T淋巴细胞亡中的作用.
- 阐明不同淋巴细胞群体中IRF-1,p53和亡之间的关系.
主要方法:
- 利用成熟T淋巴细胞的线粒原激活.
- 研究了DNA损伤诱导的亡.
- 评估了干扰素调节因子 (IRF) -1 的作用.
- 检查了介素-1β转化酶 (ICE) 基因表达的诱导.
- 进行了IRF-1的宫外过度表达.
主要成果:
- 成熟T淋巴细胞中DNA损伤诱导的亡依赖于转录因子IRF-1.
- 在乳腺细胞中,IRF-1调解了一条与p53依赖的途径分开的明显的亡途径.
- ICE基因的基因诱导是依赖IRF-1的.
- 宫外IRF-1表达激活内源性ICE并增加对辐射诱导的亡的敏感性.
结论:
- 两个不同的抗瘤转录因子,p53和IRF-1,调节T淋巴细胞中的单独的亡途径.
- 在成熟的T淋巴细胞中,IRF-1在DNA损伤诱导的亡和ICE基因调节中发挥着关键作用.
- IRF-1 代表了细胞防御对淋巴细胞中DNA损伤的关键因素.
相关概念视频
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...


